Evidence map›Paper›PMID 21057834›Full record

ReviewEuropean child & adolescent psychiatry2011

Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry.

Celso Arango

Abstract readReview
PubMed Publisher
In one paragraph

Review in European child & adolescent psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Introduction to the Special Section onResearch in psychotherapy (Milano) · 2020
    Article
  8. Article
  9. Article
  10. Schizophrenia spectrum and other psychotic disorders.European child & adolescent psychiatry · 2013
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. On the way to DSM-V.European child & adolescent psychiatry · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Celso ArangoUnidad de Adolescentes, Departamento de Psiquiatría, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, C/Ibiza, 43, 28009 Madrid, Spain. carango@hggm.es
Centro de Investigación Biomédica en Red de Salud Mental · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DSM-5 task force on schizophrenia and psychotic disorders have recently proposed to include attenuated psychotic symptoms syndrome as a disorder not currently listed in DSM-IV-TR, either in the main manual or in an Appendix for further research. One of the potential benefits of including this diagnosis in DSM-5 is to identify persons at high risk of developing psychotic disorders to prevent the appearance of these disorders or lead to disorders with a better prognosis. One of the challenges applying the criteria proposed to the pediatric population is the difficulty in defining "attenuated" in the same way and it is done with adults. The threshold for psychosis may be lower in children and, therefore, what is attenuated in adults may be fully present, although transient, in paediatric population. Other potential risks are a lower threshold for prescribing antipsychotics without clear evidence and whether the help-seeking behaviour criterion will be applied to the patients and/or the parents.

Indexed as

Diagnostic and Statistical Manual of Mental DisordersAdolescentAdultChildHumansPsychotic Disorders

Identifiers

PMID21057834
OpenAlexW1990336378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.